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Background After inflammatory stimulus, mast cells (MC) migrate to secondary lymphoid organs contributing to adaptive immune response. There is growing evidence that MC also contribute to transplant tolerance, but little is known about MC kinetics in the setting of transplant tolerance and rejection. Likewise it has been demonstrated that complement split products, which are known to act as chemoattractants for MC, are necessary for transplant tolerance.

Methods Naive skin and lymph nodes, skin grafts and draining lymph nodes from wild type and complement deficient mice treated with a tolerogenic protocol were analyzed. 

Results Early after tolerance induction MC leave the graft and migrate to the draining lymph nodes. After this initial efflux, MC reappear in tolerant skin grafts in numbers exceeding that of naive skin. MC density in draining lymph nodes obtained from tolerant mice also increased post transplant. There was no difference in MC density, migration and degranulation status between wild type and complement deficient mice implicating that chemotaxis is not disturbed in complement deficient mice.

Conclusion This study gives detailed insight in kinetics of MC migration during transplant tolerance induction and rejection providing further evidence for a role of MC in transplant tolerance.
1. Introduction 
Recent studies have shown that mast cells (MC) play an important role in innate and adaptive inflammatory responses []. Beside their well described role in allograft rejection [] MC are also necessary in the establishment of peripheral tolerance after skin and solid organ transplantation  ADDIN EN.CITE []. The functional need for MC during the initiation phase of tolerance was demonstrated in a murine skin graft model  ADDIN EN.CITE [] and a heterotopic heart transplant model  ADDIN EN.CITE []. Recently it has been proposed that MC act via direct interaction with T-regulatory cells  ADDIN EN.CITE [, ], but the mechanisms of MC mediated transplant tolerance are not understood.

Secondary lymphoid organs are essential for initiating the immune response to microbial antigens. After inflammatory stimulus MC migrate to the draining lymph nodes where they interact with B and T lymphocytes  ADDIN EN.CITE []. In transplantation, secondary lymphoid organs play an important role in rejection response and tolerance induction []. However migration of MC between donor graft and secondary lymphoid organs received little attention. This study investigates the kinetics of MC migration into and out of the donor organ and draining lymph nodes during tolerance induction and rejection.

It has been shown that the complement system is important for the induction and maintenance of tolerance  ADDIN EN.CITE []. This effect is mediated via complement split product iC3b binding on complement receptor 3 on antigen presenting cells. Recent publications demonstrated complement component 3 (C3) and complement component 3a receptor (C3aR) to be crucial for HY specific transplant tolerance induction  ADDIN EN.CITE [, ]. However the underlining mechanisms for this complement dependant tolerance are not known. The complement system is able to activate MC via C3 split products [] and complement component 3a (C3a) is a strong chemoatractant for MC []. We hypothesized that one of the mechanisms that account for complement dependant transplant tolerance is migration of MC from the graft to the secondary lymphoid organs via C3 split product induced chemotaxis. To test this hypothesis we analyzed MC migration in a murine model of complement dependant tolerance.
2. Materials and Methods
2.2. Mice
Animals were kept in specific pathogen free animal facilities and were used between the age of 8 and 12 weeks in accordance with the Animals (Scientific Procedures) Act 1986.  C57BL/6 mice were purchased from Harlan Limited (UK) and Charles River (MA, USA). Homozygous C3-/- and C3aR-/- C57BL/6 mice were kind gifts from Drs M Carroll and Bao Lu, respectively (Harvard Medical School). 

2.3. Skin transplantation and definition of rejection
Skin transplantation was performed as previously described [], except full thickness trunk skin, was used instead of tail skin. Rejection was defined by >90% macroscopic necrosis of the skin. Mice were checked daily.

2.4. Donor lymphocyte infusion protocol
For donor lymphocyte preparation male spleens were harvested, mashed through a 40µm cell strainer and washed in phosphate buffered saline (Oxoid, UK). Red blood cells were removed using an ammonium chloride-based lysing reagent (BD Pharm Lyse; BD Pharmingen, USA) according to the manufacturer’s instructions. After washing cells in phosphate buffered saline thirty five million cells were injected into recipients via the tail vein immediately before skin transplantation.

2.5. Histology
Frozen tissue samples were cut into 8m sections.  MC granule stain was performed with Toluidine-blue. Slides were fixed in acetone/methanol (Sigma, MO, US) 1:1 solution for 5 minutes and stained for 5 minutes with Toluidine-blue staining solution (0.5% w/v Toluidine-blue in 0.5 N hydrogen chloride acid; Sigma). Slides were analyzed by a Diplan microscope (Leitz, Germany) and a DXM1200DF digital camera (Nikon, Japan), using Lucia G software (Nikon). Positive cells were counted in at least 20 random high power fields (x400) of each sample by an observer blinded to the experimental conditions.

2.6. Immunohistochemistry
For immunohistochemistry standard methods were used []. Slides were incubated with a rat IgG2A anti-mouse stem cell factor R/c-kit monoclonal antibody (clone 180627; R&D Systems, UK) and visualized with a biotinylated goat anti-rat polyclonal antibody (Pharmingen, CA, US) followed by a and streptavidin-horse radish peroxidase conjugate (Pharmingen) and Vector NovaRed Substrate kit (Vector Laboratories) used according to the manufacturer’s protocol. Sections were analyzed as described above.

2.7. Statistical analysis
Kaplan Meier analysis was applied to calculate graft survival. Numbers of MC are displayed as median per mm2. Mann Whitney U Test was used to compare density of MC between groups. All tests were two-sided, with a 5% type I error. Statistical calculations were performed using SPSS for Windows, version 17.0 (SPSS Inc., USA).
3. Results
3.1. MC in tolerant skin grafts
First we analyzed MC density in naive trunk skin from male C57BL/6 wild type (WT) mice. As shown in figures 1and 2a, MC granule stain with Toluidine-blue revealed an average of 41 MC per mm2. For analysis of MC density in tolerant skin grafts male WT trunk skin was transplanted to female WT recipients in combination with a donor lymphocytes infusion. This protocol leads to specific tolerance induction towards the male HY antigen and thus to indefinite graft survival whereas without donor lymphocyte infusion skin grafts are chronically rejected  ADDIN EN.CITE [, ]. At day 7 after transplantation 10 MC per mm2 were detectable in the skin grafts harvested from tolerant mice, which was significantly less compared to naive skin (p=0.001). Similar results were obtained at day 7 in skin grafts from rejecting controls (18 MC/mm2, p=0.08), whereas syngeneic skin graft controls had MC numbers comparable to naive skin (37 MC/mm2, p=0.4). These data demonstrate that MC density within minor mismatched skin grafts is reduced compared to naive skin, irrespective of the graft outcome.

In order to characterize the kinetics of MC in donor specific tolerance in more detail, we analyzed donor skin grafts from mice treated with donor lymphocyte infusion over time (figures 3, 2b). From day 14 post transplantation MC density in tolerant skin grafts began to increase, exceeding numbers obtained from naive skin  at day 50 (87 MC/mm2, p=0.02) and  at day 100 (73 MC/mm2, p=0.04). In contrast there was no significant difference in MC density between syngeneic skin graft controls at day 100 and naive skin (65 MC/mm2, p=0.1). Taken together these results demonstrate that after an initial reduction in MC density in tolerant grafts, cell numbers rise over time exceeding those detected in naive skin.

It has been shown that MC escape granule stain after complete degranulation  ADDIN EN.CITE [, ]. Therefore we performed a MC surface stain with c-kit to analyze the total MC density independently of the degranulation status (figures 1, 2a). Within naive skin 56 MC per mm2 were counted which was not significantly different compared to the Toluidine-blue granule stain (p=0.2). Similar to Toluidine-blue stains, skin grafts harvested from tolerant mice stained with c-kit showed markedly reduced MC density at day 7 after transplantation compared to naive skin (11 MC per mm2, p=0.003). Surface stain in rejecting and syngeneic controls showed also similar results compared to those obtained from Toluidine-blue stain and there was no significant difference in MC density between tolerant skin grafts and rejecting controls (p=0.9). This suggests that the observed reduction in MC density early after transplantation is not due to MC degranulation and that there is no difference in the amount of MC degranulation between tolerant and rejecting grafts.

3.2. MC in draining lymph nodes of skin grafts
It has been shown that MC traffic from the local site of inflammation to secondary lymphoid organs  ADDIN EN.CITE []. Therefore, we investigated if the observed reduction in MC density in the skin grafts early after transplantation was the result of MC migration to the draining lymph nodes. We found an average of 10 MC per mm2  detected by Toluidine-blue stain in draining lymph nodes from tolerant mice at day 7 after skin graft transplantation, which is significantly more compared to numbers in lymph nodes harvested from naive mice (1.4 MC/mm2, p=0.008; figures 4, 2c). There was no difference compared to lymph nodes harvested from rejecting controls (8 MC/mm2, p=0.9), but there were less MC in the draining lymph nodes harvested from syngeneic controls (3 MC/mm2, p=0.03; figures 5, 2d). A longitudinal analysis revealed that from day 14 after transplantation MC numbers within draining lymph nodes from tolerant mice further rose with a maximum at day 100 post transplantation (80 MC/mm2; figure 5). The expansion of MC in draining lymph nodes from tolerant mice was predominantly in the sub capsular region, suggesting an influx of MC via the afferent lymphatics (figure 5). In contrast MC numbers in draining lymph nodes from syngeneic controls did not increase in the same way over time (19 MC/mm2; figure 5).

3.3. MC in C3-/- and C3aR-/- skin grafts
Having established that MC migrate from skin grafts into draining lymph nodes early after transplantation, and re-accumulate in tolerant skin grafts with time, we investigated whether factors known to influence MC migration would affect this process.  Therefore we analyzed complement and complement receptor deficient mice. As shown in figures 6 and 2e Toluidine-blue granule stain of naive skin from C3-/- mice revealed an average of 35 MC/mm2 which is not significantly different compared to naive skin from WT mice (p=0.24). However there was only half the amount of MC detectable in naive skin from C3aR-/- mice compared to WT animals (21 MC/mm2, p=0.004). Next we analyzed skin grafts obtained from complement and complement receptor deficient recipients treated with the same tolerance induction protocol used in WT animals. Female C3-/- and C3aR-/- mice received a male C3-/- and C3aR-/- skin graft in combination with a C3-/- and C3aR-/- donor lymphocyte infusion respectively. This model of complement dependent tolerance leads to chronic rejection of the graft  ADDIN EN.CITE [, ]. At day 7 after transplantation 9 MC per mm2 could be detected in C3-/- male skin grafts, which is less compared to naive C3-/- skin (p=0.002). However there was no significant difference compared to MC density described within grafts of similar treated tolerant WT mice at day 7 after transplantation (p=0.9). Likewise skin grafts from C3aR-/- mice showed reduced MC density at day 7 after transplantation in comparison to naive C3aR-/- skin (4 MC/mm2, p=0.004), which is not significantly different compared to tolerant WT skin grafts at day 7 after transplantation (p=0.1).

MC surface stain with c-kit revealed no significant difference in MC density between naive skin from C3-/- mice and WT mice (p=0.5; figure 6). However there were fewer MC within naive skin from C3aR-/- mice compared to WT mice (p=0.016). Skin grafts from C3-/- and C3aR-/- mice showed a significantly lower MC density compared to naive skin from C3-/- and C3aR-/- mice respectively (8 MC/mm2, vs. 51 MC/mm2, p=0.029 and 6 MC/mm2 vs. 27 MC/mm2, p=0.016 respectively). Compared to skin grafts from tolerant WT mice, skin grafts from C3-/- mice showed no significant difference in MC numbers (p=0.2). In contrast there were significantly more MC in skin grafts from tolerant WT animals compared to skin grafts from C3aR-/- mice (p=0.029). Of note this difference in absolute MC numbers did not result in a difference in relative MC numbers, taken into account the MC density within naive skin from C3aR-/- and WT mice. A relative reduction of 81% MC was calculated for C3aR-/- and 79% for WT mice respectively. These data suggest that similar to WT animals there is a MC efflux from skin grafts in complement deficient and complement receptor deficient mice early after transplantation.

3.4. MC in draining lymph nodes of C3-/- and C3aR-/- skin grafts
To determine whether the observed MC efflux is due to migration to local lymph nodes we harvested draining lymph nodes from C3-/- and C3aR-/- mice at day 7 after transplantation (figure 4). There were more MC detectable in draining lymph nodes from skin grafts compared to lymph nodes harvested from naive animals (9 MC/mm2 vs. 1.8 MC/mm2 for C3-/- mice, p=0.004 and 12 MC/mm2 vs. 1.4 MC/mm2 in C3aR-/- mice, p=0.005 respectively). However there was no significant difference compared to draining lymph nodes harvested from tolerant WT mice (p=0.4 for C3-/- and p=0.9 for C3aR-/- mice respectively). Taken together these data suggest that after antigen stimulus MC migration to draining lymph nodes is not impaired in the absence of chemotactic complement split products.

4. Discussion
MC have been described as mediators of allograft rejection [], but recent data provide evidence for a function in the induction and maintenance of transplant tolerance []. It is also known that after antigen stimulus MC migrate to secondary lymphoid organs contributing to the adaptive immune response []. The object of the present work was to analyze MC kinetics during transplant tolerance induction. In addition we analyzed the contribution of complement split products to MC migration. Our data suggest that early after tolerance induction, MC leave the graft and migrate to the draining lymph nodes. After this initial efflux MC reenter tolerant grafts exceeding numbers in naive skin. MC density in draining lymph nodes of tolerant skin increases in a similar way during the whole post transplant period. Analyzing known chemotactic factors regulating MC traffic our data showed that migration is not defective in complement deficient mice. Taken together our data provide new insight in MC migration during transplant tolerance induction and rejection and further evidence for a role of MC in allograft tolerance.

We observed a reduction in MC density  within skin grafts early after transplantation, which was described earlier by Noelle and colleagues  ADDIN EN.CITE []. In contrast to their observations we did not notice a difference between MC density in tolerant and rejecting grafts. In our model reduction of MC took place irrespective of the graft outcome. This reduction was restricted to the presence of HY antigen, as syngeneic controls showed no reduced MC density. Similar to rejection, HY specific tolerance induction requires an active interaction of antigen presenting cells with T-cells []. During rejection the presentation of donor antigen by recipient antigen presenting cells leads to T-cell activation, whereas the presentation of the HY antigen to T-cells by donor antigen presenting cells leads to tolerance induction. It has been shown in models of inflammation that MC migrate from the primary site, to the draining lymph nodes   ADDIN EN.CITE [] where they participate in induction of a primary immune response directly via T lymphocyte recruitment  ADDIN EN.CITE [], differentiation  ADDIN EN.CITE [], stimulation  ADDIN EN.CITE [] and indirectly via dendritic cell maturation [], antigen uptake and presentation  ADDIN EN.CITE [] and chemotaxis  ADDIN EN.CITE []. Furthermore it is described that MC have antigen presenting function themselves []. Therefore we postulate that in our model the reduction in MC density is due to MC migration to draining lymph nodes. Their interaction with T and B lymphocytes and antigen presenting cells within the secondary lymphoid organs contributes to tolerance induction and rejection in our transplant model. There are other possible mechanisms than migration to draining lymph nodes that might explain the differences in MC numbers between naive skin and skin grafts observed in our study. First, after complete degranulation MC might escape granule stain []. MC surface stain produced similar results, which makes this explanation unlikely. Secondly MC might have been eliminated by direct cytotoxic elimination through the host. We cannot exclude that donor MC have been partly eliminated by this mechanism in our model.

Analyzing kinetics of MC migration over time we observed that MC density normalizes in tolerant grafts from day 14, even exceeding numbers obtained from naive skin from day 50. Interestingly such an increase could not be observed in a similar way in syngeneic controls. These data suggest a possible role for MC in the maintenance of transplant tolerance. The described increase in MC density could be explained by recruitment of progenitors from the circulation, local proliferation of resident MC or migration of MC from adjacent tissues and secondary organs. Other groups have also described a normalization of MC numbers over time, but increased numbers of MC in tolerant tissue compared to naive tissue have not been reported yet  ADDIN EN.CITE [, ]. This discrepancy might be explained due to the longer observation time in our experiments. It has been shown that MC play an essential role in wound healing and accumulate at the site of injury []. Since we did not detect an increased density of MC in syngeneic grafts over time in the same way and MC density was still rising after complete wound healing it is unlikely that repair mechanisms account for the observed increase of MC density. Longitudinal observations are limited by the fact that chronic rejecting controls and complement deficient animals could not be analyzed as grafts are already rejected from day 7. 

We detected an increased number of MC in draining lymph nodes from skin grafts after transplantation in comparison to naive lymph nodes, which has also been demonstrated in models of inflammation and allergy  ADDIN EN.CITE []. However such an increase in MC density in draining lymph nodes has not been described in transplant studies  ADDIN EN.CITE []. Interestingly no increase was detected in draining lymph nodes from syngeneic skin grafts. The parallel increase in MC density in draining lymph nodes and decrease of MC density in tolerant and rejecting skin grafts, as well as the predominant increase in the subcapsular region within the draining lymph nodes strongly argue for a MC migration from the skin grafts to the draining lymph nodes early after antigen contact. However we cannot exclude a contribution of local MC proliferation or influx of immature MC progenitiors. Further increase in MC density in draining lymph nodes was observed in longitudinal analysis of tolerant mice. In contrast MC numbers in draining lymph nodes from syngeneic controls did not increase in the same way over time. This observation demonstrates that MC accumulate in draining lymph nodes during maintenance of transplant tolerance.

Data obtained from C3 and C3aR deficient mice suggest that MC migration to secondary lymphoid organs is not impaired in the absence of complement split products. The versatility of the MC lies in its ability to be to receptive to a variety of chemotactic stimuli. It is known that not only complement split products but also various chemokines, which are secreted during the inflammatory response, such as CCL5, CXCL-10, IL-8, IL-3, and TNF  ADDIN EN.CITE [] are chemotactic for MC. In this regard it is likely that the lack of anaphylatoxins during the antigen stimulation can be substituted by other chemoatractants.

In summary this study provides novel insight in MC kinetics during transplant tolerance induction and rejection. We provide evidence that early after antigen contact MC leave the graft, migrate to the draining lymph nodes and re enter tolerant grafts thereafter. This migration is not defective in complement deficient mice. 
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Figure legends
Figure 1. MC granule and surface stain of naive skin and skin grafts from WT mice. Female mice received male trunk skin after infusion of 35x106 male splenocytes. Rejecting and syngeneic controls did not receive donor splenocytes infusions. Skin grafts were harvested at day 7 after transplantation and analyzed by means of Toluidine-blue granule stain (open circle) and c-kit surface stain (open triangle). (A) Numbers of MC calculated within skin grafts obtained from donor lymphocyte induced tolerant mice did not differ from those obtained from rejecting controls. In contrast MC density within skin grafts obtained from syngeneic controls was significant higher compared to tolerant grafts and did not differ from numbers obtained from naive skin. There was no significant difference between MC granule and surface stain. Dot plots represent groups of three to nine animals. 

Figure 2
(a) Representative examples of naive skin (I, III) and tolerant skin graft (II, IV) samples. I, II: MC granules are stained dark purple (bold black arrow) and cell nuclei and keratin are stained light blue with Toluidine-blue granule stain. III, IV: MC (open arrow) and keratin are stained red-brown with c-kit surface stain. 
(b) Representative examples of naive skin (V) and long term follow up tolerant (I-IV) and syngeneic skin graft (VI) samples from WT mice. MC granules are stained dark purple (bold black arrow) and cell nuclei and keratin are stained light blue with Toluidine-blue stain.
(c) Representative examples of naive lymph nodes (II, IV, VI) and draining lymph nodes (I, III, V) from skin grafts obtained from WT (I, II), C3-/- (III, IV) and C3aR-/- (V, VI) mice. MC granules are stained dark purple (bold black arrow) and cell nuclei and keratin are stained light blue with Toluidine-blue stain.
(d) Representative examples of long term follow up tolerant (I-IV) and syngeneic skin grafts (V, VI) from WT mice. MC granules are stained dark purple (bold black arrow) and cell nuclei and keratin are stained light blue with Toluidine-blue stain. 
(e) Representative examples of naive skin (I, III, V) and skin grafts (II, IV, VI) from WT (I, II), C3-/- (III, IV) and C3aR-/- (V, VI) mice. MC granules are stained dark purple (bold black arrow) and cell nuclei and keratin are stained light blue.
(f) Representative examples of naive skin (I, II) and tolerant skin grafts (III, IV) from C3-/- (II, IV) and C3aR-/- (I, III) mice. MC (bold arrow) and keratin are stained red-brown with c-kit surface stain.


Figure 3. MC granule stain of naive skin and long term follow up skin grafts from WT mice. Female mice received male trunk skin after infusion of 35x106 male splenocytes. Syngeneic controls did not receive donor splenocytes infusions. Skin grafts were harvested at day 7, 14, 50 and 100 after transplantation and analyzed by means of Toluidine-blue granule stain. (A) After an initial reduction early after transplantation, MC density within tolerant skin grafts (open circle) rises from day 14, exceeding numbers obtained from naive skin (open triangle) from day 50. In contrast syngeneic controls (open diamond) did not show a similar increase in MC density and did not have a significant difference in MC numbers compared to naive skin at day 100 after transplantation. Dot plots represent groups of three to eight animals. 

Figure 4. MC granule stain of lymph nodes from naive skin and draining lymph nodes from skin grafts from WT and complement deficient mice. Female mice received male trunk skin after infusion of 35x106 male splenocytes. Draining lymph nodes were harvested at day 7 after transplantation and analyzed by means of Toluidine-blue granule stain. (A) More MC were detected in draining lymph nodes from skin grafts compared to naive lymph nodes obtained from WT(open circle) and complement deficient animals (C3-/- open triangle and C3aR-/- open diamond) . No significant difference between draining lymph nodes from skin grafts obtained from WT and complement deficient mice was detected. Dot plots represent groups of five to nine animals. 


Figure 5. MC granule stain of draining lymph nodes from long term follow up WT skin graft recipients. Female mice received male trunk skin after infusion of 35x106 male splenocytes. Syngeneic and rejecting controls did not receive donor splenocytes infusions. Draining lymph nodes were harvested at day 7, 14, 50 and 100 after transplantation and analyzed by means of Toluidine-blue granule stain. (A) There was no difference between MC density in draining lymph nodes obtained from tolerant mice (open circle) compared to lymph nodes obtained from chronic rejecting controls (open square) at day 7 after transplantation. However there were less MC in the draining lymph nodes obtained from syngeneic controls (open triangle) compared to lymph nodes obtained from tolerant mice at day 7 after transplantation. MC density within draining lymph nodes obtained from tolerant animals rose from day 14, whereas MC density in lymph nodes obtained from syngeneic controls did not change in a similar way. The expansion of MC in tolerant mice was predominantly in the sub capsular region of the draining lymph nodes. Dot plots represent groups of three to five animals. 
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